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a b s t r a c t
Post-transcriptional events regulate herpesvirus gene expression, yet few herpesvirus RNA-binding proteins
have been identiﬁed. We used an unbiased approach coupling oligo(dT) afﬁnity capture with proteomics to
identify viral RNA-associated proteins during infection. Using this approach, we identiﬁed and conﬁrmed
changes in the abundance or activity of two host RNA-associated proteins, DHX9 and DDX3, in cells infected
with human cytomegalovirus (HCMV). We also identiﬁed and conﬁrmed previously unreported activities for
the HCMV US22 and pp71 proteins as RNA-associated viral proteins and conﬁrmed that a known viral RNA-
binding protein, pTRS1, associates with RNA in infected cells. Further, we found that HCMV pp71 co-
sedimented with polysomes, associated with host and viral RNAs, and stimulated the overall rate of protein
synthesis. These results demonstrate that oligo(dT) afﬁnity capture coupled with proteomics provides a rapid
and straightforward means to identify RNA-associated viral proteins during infection that may participate in
the post-transcriptional control of gene expression.
Published by Elsevier Inc.
Introduction
Human cytomegalovirus (HCMV) is a ubiquitous human patho-
gen that infects the majority of the population (Cannon et al.,
2010). Healthy individuals carry HCMV asymptomatically for the
rest of their lives. However, immune-compromised individuals are
at risk for severe life threatening disease caused by reactivated
HCMV infections (Nogalski et al., 2014). In addition, HCMV can be
congenitally passed from mother to child during pregnancy and
HCMV is a leading cause of infectious birth defects (Kenneson and
Cannon, 2007).
Regulation of HCMV gene expression is complex and occurs at
both transcriptional and post-transcriptional levels. Like host mRNAs,
viral precursor RNAs are transcribed and mature in the nucleus, and
then transported to the cytosol where they are translated into
protein. Ribonucleoprotein (RNP) complexes play a critical role in
each step of host mRNA maturation and quality control (Anderson
and Kedersha, 2008; Dreyfuss et al., 2002) and therefore play
important roles in the post-transcriptional control of gene expres-
sion. Herpesvirus transcripts are also subject to post-transcriptional
regulation. However, unlike host transcripts, many herpesvirus
transcripts are unspliced and therefore require a distinct complement
of RNPs for their maturation and export (Sandri-Goldin, 2004). For
example human herpesviruses encode homologs of the HCMV UL69
protein (pUL69), which interacts with the host RNA export machin-
ery and facilitates the transport of unspliced viral mRNAs into the
cytoplasm (Lischka et al., 2001, 2006). In addition herpesvirus
proteins manipulate host post-transcriptional regulatory systems in
order to modify the expression of antiviral host messages and
miRNAs (Bryant et al., 2001; Lee et al., 2013; Lindberg and Kreivi
2002; Sciabica et al., 2003). For HCMV, post-transcriptional regula-
tion plays an essential role in the kinetics of viral gene expression.
mRNAs for several late genes are transcribed early in infection;
however, late mRNAs are not translated into protein until viral DNA
replication occurs (Geballe et al., 1986; Smith et al., 1992). Whether
HCMV encodes additional proteins that impact post-transcriptional
control of viral gene expression remains unknown.
One approach to identify proteins involved in post-transcriptional
regulation of gene expression involves the identiﬁcation of RNA-
associated proteins. For example, RNA-afﬁnity chromatography coupled
with mass spectrometry has been used to identify RNA-binding
proteins in mammalian cells (Baltz et al., 2012; Castello et al., 2012).
Similar strategies have been used to deﬁne host and viral proteins that
associate with speciﬁc viral RNAs (Lenarcic et al., 2013; Li et al., 2014;
Pacheco et al., 2009). Such approaches have proven useful in deﬁning
the complement of RNA-binding proteins that might participate in RNA
metabolism, trafﬁcking, or translation.
In order to identify HCMV proteins that might function in post-
transcriptional regulation, we used an unbiased proteomics approach
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based on oligo(dT) afﬁnity puriﬁcation to identify mRNA-associated
proteins during HCMV infection. We ﬁnd that infection alters the
abundance and activity of two host RNA-binding proteins, DHX9 and
DDX3X. In addition, we identiﬁed and conﬁrmed previously unde-
scribed mRNA-binding activities for the HCMV US22 protein and the
viral tegument protein pp71. Further studies revealed that pp71
bound mRNA throughout a time course of infection and associated
with polysomes in HCMV infected cells. Both host and viral mRNAs
co-puriﬁed with pp71 from infected cell lysates and pp71 associated
with mRNA in the absence of additional viral proteins. Together these
results demonstrate the utility of oligo(dT) afﬁnity capture coupled
with proteomics to identify new RNA-binding activities for herpes-
virus proteins.
Results
Unbiased proteomic proﬁling of RNA-associated proteins in HCMV-
infected cells
In order to identify proteins associatedwithmRNA during infection,
we performed an unbiased screen for proteins that co-purify with
oligo(dT) cellulose from HCMV infected cells. Fig. 1 shows the basic
details of the assay. Human foreskin ﬁbroblasts (HFFs) were infected
with HCMV for 72 h and then lysed in a buffer containing high salt
(500mM NaCl) in order to limit non-speciﬁc protein:protein interac-
tions. mRNA:protein complexes were isolated by incubating the lysates
with oligo(dT) conjugated cellulose beads. As high salt concentrations
lower the base pairing stringency of RNA:DNA interactions (Tan and
Yiap, 2009), we decreased the salt concentration during the wash and
elution steps to limit non-speciﬁc RNA binding to the oligo(dT) DNA
oligomers. A substantial source of false positives in proteomics experi-
ments arises from non-speciﬁc binding of proteins to the afﬁnity
matrix (Rowles et al., 2013). Therefore the mRNA:protein complexes
were eluted from the beads by the addition of excess soluble oligo(dT),
leaving non-speciﬁc interactors bound to the matrix. The eluted lysates
were separated on SDS-PAGE gels and visualized by Coomassie
staining (Fig. 1B). Numerous bands were enriched in abundance in
the oligo (dT) eluates as compared to whole cell lysates. The eluates
from HCMV infected cells appeared to contain all of the bands found in
uninfected eluates, along with several unique bands (Fig. 1B). We
performed the assay in the presence of micrococcal nuclease in order
to visualize levels of nonspeciﬁc proteins bound to the beads in the
absence of RNA (Fig. 1B). While some non-speciﬁc interactors
remained, micrococcal nuclease treatment reduced the number and
intensity of bands, suggesting that many of the captured proteins were
retained in an RNA-dependent manner.
The complement of proteins in the oligo(dT) eluate was determined
using liquid chromatography coupled with tandem mass spectrometry
(LC–MS/MS). Initial inspection of the eluted proteins revealed that both
infected and uninfected samples contained many known RNA-binding
proteins (Table 1, Table S1). Gene ontogeny analysis revealed that
the set of proteins enriched in the oligo(dT) eluate were signiﬁ-
cantly associated with RNA-binding, post-transcriptional regulation,
17
11.4
10.5
10.510.3
9
8.2
7.9
7.7 7.5
RNA binding
nucleotide binding
gene expression
RNA splicing
RNA binding
spliceosome
RNA/gene expression
Infect HFFs
High Salt Lysis
-limits non-specific
protein interactions
Oligo (dT) cellulose capture
Low Salt Wash
-increase RNA binding 
stringency
Elute w/ free oligo (dT)
-increase specificity
LC-MS/MS
+-MN
Fig. 1. Oligo(dT) capture combined with mass spectrometry identiﬁes HCMV proteins associated with mRNA. (A) Flow chart of the method used to identify HCMV mRNA
associated proteins. (B) Proteins isolated using the method in A were separated by SDS-PAGE and visualized using GelCode Blue staining. Left panel; the effect of micrococcal
nuclease treatment on the complement and intensity of oligo(dT)-associated proteins. Right panel; gel showing oligo(dT)-associated proteins isolated from uninfected or
HCMV-infected ﬁbroblasts. Arrows denote bands speciﬁc to infected cells. (C) Gene ontogeny analysis shows that cellular proteins detected by LC–MS/MS after oligo (dT)
capture are signiﬁcantly enriched for RNA-associated functions.
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and splicing (Fig. 1C). This analysis suggests that our assay enriched for
proteins that interact with RNA in both uninfected and infected
primary ﬁbroblasts.
To gain a sense of whether infection changes the abundance of
host proteins associated with mRNA, we compared total spectral
counts for individual host proteins detected in the mock and
HCMV infected samples. Our data suggested that infection might
increase the association of several host proteins with mRNA. Two
such host proteins, the RNA helicases DDX3X and DHX9 were
selected for further analysis. Both proteins co-puriﬁed with oligo
(dT) from uninfected cell lysates (Fig. 2A), consistent with previous
results (Lee and Hurwitz 1992; Yedavalli et al., 2004). Micrococcal
nuclease treatment inhibited binding of both proteins, demon-
strating that the association was dependent on the presence of
RNA and not the result of non-speciﬁc interactions with the
cellulose beads (Fig. 2B). Infection increased the amount of each
protein associated with mRNA, stimulating the binding of DHX9 to
a greater extent than DDX3X (Fig. 2A). The increased association
was likely due to the increased levels of DDX3X and DHX9
observed in HCMV-infected cells. We conclude that HCMV infec-
tion changes the abundance of two host RNA-binding proteins
associated with mRNA during infection. While our data suggests
similar changes may occur for additional host proteins, we caution
that further studies are needed to conﬁrm these changes for
individual host proteins.
HCMV pTRS1 and pUS22 associate with mRNA in HCMV infected cells
In addition to cellular proteins, oligo(dT) eluates from infected
cells also contained viral proteins (Table S1). Two of the viral
Table 1
Host RNA-associated proteins identiﬁed by oligo(dT) proteomics. Listed are the uniprot accession numbers (http://www.uniprot.org/) and gene names for the top thirty
identiﬁed host proteins. The third column notes previous studies demonstrating an RNA-associated activity for the speciﬁed protein.
Uniprot Gene description RNA associated activity
P52272 Heterogeneous nuclear
ribonucleoprotein M
Datar et al., 1993; Gattoni et al., 1996; Kafasla et al., 2002; Lleres et al., 2010
P11940 Polyadenylate-binding protein
1
Coller et al., 1998; Cosson et al., 2002; Gray et al., 2000; Lleres et al., 2010; Wells et al., 1998
P22626 Heterogeneous nuclear
ribonucleoproteins A2/B1
Beyer et al., 1977; Jonson et al., 2007; Pinol-Roma et al., 1988; Wilk et al., 1985
P23246 Splicing factor, proline- and
glutamine-rich
Gozani et al., 1994; Patton et al., 1993; Shav-Tal and Zipori, 2002
P27694 Replication protein A 70 kDa
DNA-binding subunit
Q00839 Heterogeneous nuclear
ribonucleoprotein U
Fackelmayer et al., 1994; Kiledjian and Dreyfuss 1992; Yugami et al., 2007
P07910 Heterogeneous nuclear
ribonucleoproteins C1/C2
Beyer et al., 1977; Brunner et al., 2010; Huang et al., 1994; Pinol-Roma et al., 1988; Wilk et al., 1985
P08670 Vimentin
Q13310 Poly(A) binding protein 4 Jonson et al., 2007
P14866 Heterogeneous nuclear
ribonucleoprotein L
Guang et al., 2005; Hung et al., 2008; Hwang et al., 2009; Liu and Mertz 1995; Pinol-Roma et al., 1989; Shih and Claffey 1999
P16989 Y-box-binding protein 3
O43390 Heterogeneous nuclear
ribonucleoprotein R
Hassfeld et al., 1998; Jonson et al., 2007
O15523 ATP-dependent RNA helicase
DDX3Y
Ariumi 2014; Geissler et al., 2012; Kasim et al., 2013; Lai et al., 2008; Merz et al., 2007; Shih et al., 2012; Soto-Rifo et al., 2012;
Yedavalli et al., 2004
O00571 ATP-dependent RNA helicase
DDX3X
Ariumi 2014; Geissler et al., 2012; Kasim et al., 2013; Lai et al., 2008; Merz et al., 2007; Shih et al., 2012; Soto-Rifo et al., 2012;
Yedavalli et al., 2004
Q04837 Single-stranded DNA-binding
protein, mitochondrial
Q96G97 Seipin
Q15233 Non-POU domain-containing
octamer-binding protein
Basu et al., 1997; Shav-Tal and Zipori, 2002; Zhang and Carmichael, 2001
Q96AE4 Far upstream element-binding
protein 1
Jacob et al., 2014; Li et al., 2013
O14979 Heterogeneous nuclear
ribonucleoprotein D-like
Kawamura et al., 2002; Omnus et al., 2011
P51991 Heterogeneous nuclear
ribonucleoprotein A3
Ma et al., 2002
P67809 Nuclease sensitive element
binding protein-1
Hartmuth et al., 2002; Jonson et al., 2007; Lyabin et al., 2014; Skabkin et al., 2004; Stickeler et al., 2001; Watermann et al.,
2006
O75534 Cold shock domain-containing
protein E1
Boussadia et al., 2003; Chang et al., 2004; Grosset et al., 2000
Q9Y3F4 Serine-threonine kinase
receptor-associated protein
Chari et al., 2008; Vukmirovic et al., 2013
P09651 Heterogeneous nuclear
ribonucleoprotein A1
Beyer et al., 1977; Jonson et al., 2007; Pinol-Roma et al., 1988; Wilk et al., 1985
Q9Y2W1 Thyroid hormone receptor-
associated protein 3
Lee et al., 2010; Varia et al., 2013
Q08211 ATP-dependent RNA helicase A
(DHX9)
Fuller-Pace 2006; Hartman et al., 2006; Lee and Hurwitz 1992; Li et al., 1999; Pellizzoni et al., 2001; Weidensdorfer et al.,
2009
Q15717 ELAV-like protein 1 Brennan and Steitz 2001; Weidensdorfer et al., 2009
P11142 Heat shock cognate 71 kDa
protein
Jonson et al., 2007
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proteins, pTRS1 and pUS22, contain a US22 superfamily domain,
yet the proteins differ in their subcellular localization. pTRS1 is
found predominantly in the cytoplasm throughout infection
(Fig. 3A and Romanowski and Shenk, 1997). Conversely, pUS22 is
primarily found in the nucleus (Fig. 3A, bottom (Mocarski et al.,
1988)). pTRS1 was previously shown to bind mRNA in vitro (Hakki
and Geballe, 2005), although the association of pTRS1 with mRNA
during HCMV infection has not been reported. Both pTRS1 and
pUS22 co-puriﬁed with oligo(dT) throughout a time course of
HCMV infection (Fig. 3B). Micrococcal nuclease treatment dimin-
ished the amount of pTRS1 and pUS22 that co-puriﬁed with oligo
(dT), demonstrating an RNA-dependent interaction with the beads
(Fig. 3C and D). The host poly (A) binding protein (PABP1), a well-
characterized cellular RNA-binding protein (Goss and Kleiman,
2013), was used as a control in these experiments (Fig. 3C). These
data are the ﬁrst report of pTRS1 binding to mRNA in the context
of HCMV infection and also validate the ability of oligo(dT)
coupled proteomics to capture and identify both nuclear and
cytoplasmic HCMV proteins associated with mRNA. In addition,
these data identify the ﬁrst molecular activity for HCMV pUS22 as
an RNA-associated protein.
HCMV pp71 is an RNA-associated protein
We also identiﬁed the HCMV pp71 protein in our proteomics
analysis. While several functions have been ascribed to pp71
(Cantrell and Bresnahan, 2005; Kalejta et al., 2003; Kalejta and
Shenk, 2003; Trgovcich et al., 2006) it has not previously been
shown to associate with mRNA. To examine the association of pp71
with mRNA in more detail, we measured the association of pp71
with oligo(dT) cellulose throughout a time course of HCMV infection
(Fig. 4C). pp71 co-puriﬁed with oligo(dT) cellulose as early as 24 h
after infection, and the amount of pp71 associated with the resin
increased as infection progressed. The increase in pp71 binding over
time was proportional to the increase in pp71 expression. Micro-
coccal nuclease treatment reduced pp71 co-puriﬁcation with oligo
(dT) beads, indicating that co-puriﬁcation with the beads is depen-
dent on the presence of mRNA (Fig. 4B).
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Fig. 2. HCMV infection changes the activity of host RNA-binding proteins. (A) HFFs were infected with HCMV AD169 at a multiplicity of three and harvested at the indicated
times following infection. The abundance of the host DDX3X and DHX9 proteins in oligo(dT) precipitates (bound) or total cell lysate (input) was measured by Western blot.
(B) Seventy two hours after infection oligo(dT) precipitates were isolated from infected cell lysates and analyzed by Western blot. Where indicated the samples were treated
with micrococcal nuclease (þMN) to conﬁrm that the interaction is RNA dependent. The results in A and B are representative of at least two independent experiments.
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Fig. 3. Conﬁrmation that HCMV pUS22 and pTRS1 associate with mRNA during HCMV infection. (A) HFFs were infected with HCMV strains expressing GFP-tagged TRS1
(TRS1-GFP) or US22 (US22-GFP). Seventy-two hours after infection protein localization was visualized by confocal microscopy. (B) Oligo(dT) precipitates from cells infected
with a US22GFP virus throughout a time course of infection were analyzed by Western blot with GFP (US22GFP) or TRS1-speciﬁc antibodies. (C) Cells were infected with the
US22GFP virus and oligo(dT) associated proteins were analyzed byWestern blot using GFP and PABP speciﬁc antibodies at seventy two hours after infection. Where indicated
the lysates were treated with micrococcal nuclease (þMN) prior to incubation with oligo(dT) beads. (D) Cells were infected with the TRS1GFP virus for seventy two hours
and the presence of pTRS1 in the oligo(dT) precipitate was measured by Western blot (C). All results are representative of three independent experiments.
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In order to determine if other viral factors are required for the
association of pp71 with mRNA, we determined if pp71 could
associate with mRNA outside of the context of infection. Cells were
transfected with a vector expressing pp71, and the ability of pp71 to
co-purify with oligo(dT) cellulose was determined by Western blot
(Fig. 4D). As during infection, pp71 co-puriﬁed with oligo(dT) and
micrococcal nuclease treatment inhibited the interaction. These data
conﬁrm our proteomics data and show that pp71 associates with
mRNA in HCMV-infected cells. In addition the interaction between
pp71 and mRNA is not mediated by additional viral factors.
pp71 associates with mRNA in the nucleus and cytoplasm
In newly infected cells, tegument-derived pp71 localizes in the
nucleus. In contrast, nascent pp71 localizes primarily to the
cytoplasm where it contributes to HCMV replication through an
unknown mechanism (Hensel et al., 1996). In order to visualize the
location of pp71 at various times during infection we performed
indirect immunoﬂuorescence for pp71 at various times after
infection with HCMV (Fig. 4A). As previously reported pp71 was
only found in the nucleus until 48 h post-infection, when some
pp71 began to appear in the cytoplasm. By 96 h after infection
pp71 was primarily found in the cytoplasm of infected cells. To
determine if pp71 preferentially associates with mRNA in the
nucleus or cytosol, we measured the association of pp71 with oligo
(dT) in nuclear and cytosolic extracts from infected cells. We
analyzed samples at 72 h after infection for this experiment, a
time when pp71 is present in both cellular compartments. Both
nuclear and cytosolic pp71 co-puriﬁed with the oligo(dT) cellulose
and binding in both locations was decreased by micrococcal
nuclease treatment (Fig. 4E). We conclude that pp71 can bind
mRNA in both nuclear and cytoplasmic compartments.
pp71 associates with host and viral mRNAs
Our ﬁnding that pp71 co-puriﬁed with oligo(dT) cellulose in
an RNA-dependent manner suggested that pp71 might associate
with viral transcripts during infection. We therefore measured
the association of pp71 with speciﬁc host and viral mRNAs in
HCMV-infected cells. pp71-speciﬁc immune complexes were iso-
lated from infected cell lysates and the associated RNAs were
extracted and analyzed by quantitative reverse-transcriptase real
time PCR (qRT-PCR). As a control we measured the abundance of
speciﬁc mRNAs in immune complexes speciﬁc for the HCMV IE1
protein, which is not known to associate with mRNA. pp71-speciﬁc
immune complexes were enriched for the HCMV IE1, UL44 and
UL99 mRNAs compared to the IE1 control (Fig. 5A). The host GAPDH
mRNA was also enriched in pp71 immune complexes, demonstrat-
ing that pp71 associates with a host mRNA during infection.
Ribosomal RNAs were not found in pp71 immune complexes, and
no signal was observed when the reverse transcription step was
omitted (data not shown). We conclude that pp71 associates with
mRNAs in HCMV infected cells. These results also suggest that pp71
may not discriminate between host and viral transcripts.
A portion of pp71 associates with polysomes during infection
We next determined if pp71 associates with actively translating
mRNA in HCMV infected cells. mRNAs undergoing high levels of
translation are bound by multiple ribosomes, or polysomes, which
migrate into the dense fractions of linear sucrose gradients. We
reasoned that if pp71 were associated with actively translating
mRNAs then pp71 should co-migrate with polysomes in a sucrose
gradient. Cytoplasmic lysates from HCMV-infected cells were
resolved through 10–50% linear sucrose gradients to separate
ribosomal subunits, monosomes, and polysomes. The sucrose
gradients were fractionated, and the distribution of pp71 through-
out the gradient was determined by Western blot (Fig. 6A). The
majority of pp71 localized to lighter fractions of the gradient,
which contains RNP complexes and free mRNAs (Masek et al.,
2011). However, a portion of the pp71 was detectable throughout
the gradient, including the heavier fractions containing polysomes.
In order to conﬁrm that the migration of pp71 in the gradient
reﬂected an associationwith polysomes, we determined the effect of
disrupting ribosomes on the abundance of pp71 in the polysome-
containing fractions. High concentrations of EDTA disrupt ribosomes
and thus deplete polysomes from the denser fractions of the
gradient (Burny et al., 1969). EDTA treatment reduced the abundance
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Fig. 4. HCMV pp71 associates with mRNA during HCMV infection. (A) The location of GFP or pp71 was determined throughout a time course of infection by confocal
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of ribosomes in the more dense gradient fractions as demonstrated
by the reduced abundance of the ribosomal protein S6 (rpS6)
(Fig. 6B). Consistent with previous results, the HCMV UL69 protein
(pUL69) was also present in polysome-containing fractions and its
abundance in these fractions was also diminished by EDTA treat-
ment (Fig. 6B) (Aoyagi et al., 2010). EDTA treatment also reduced the
abundance of pp71 in the polysome-containing gradient fractions.
As cytosolic lysates were used in the polysome analysis, these data
support our above conclusion that pp71 associates with mRNA in
the cytosol. We conclude that a portion of pp71 associates with
polysomes in infected cells and therefore likely interacts with
translation competent mRNAs.
The pp71-binding partner pUL35A also associates with mRNA,
however, its interaction with pp71 is RNA-independent
Another HCMV tegument protein, pUL35, has been shown to
interact with pp71 in the nucleus of infected cells (Salsman et al.,
2011). Recently, however, the smaller isoform of pUL35, pUL35A,
was also found to co-localize with pp71 in the cytoplasm. Proteomic
analysis of pUL35A found that pUL35A associates with several RNA
binding proteins during HCMV infection (Salsman et al., 2012),
suggesting that pUL35A might also associate with RNA. To deter-
mine if pUL35A associates with mRNA, we measured the ability of
pUL35A to co-purify with oligo(dT) cellulose in transfected cells.
pUL35A co-puriﬁed with oligo(dT) cellulose in an RNA-dependent
manner, as micrococcal nuclease treatment diminished the interac-
tion (Fig 7A). pUL35A also co-puriﬁed with oligo(dT) in the presence
of pp71, however the amount of pUL35A co-purifying with oligo(dT)
was slightly reduced when pp71 was present (Fig. 7A). Two isoforms
of pUL35A were consistently detected in cells transfected with both
pp71 and pUL35A: the larger isoform was only observed in the
presence of pp71. While the nature of the larger isoform is currently
unknown, this result suggests that pp71 might induce a post-
translational modiﬁcation of pUL35A that is not necessary for
pUL35A to associate with RNA. These results show that pUL35A
can associate with mRNA outside of infection. In addition these
results demonstrate that our proteomics dataset is not complete,
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and that HCMV encodes additional RNA-associated proteins not
identiﬁed by our approach.
Our ﬁnding that both pp71 and pUL35A associate with mRNA
suggested that perhaps the interaction of pUL35A and pp71 is
bridged by an RNA intermediate. In order to determine if pp71
binding to pUL35A is mRNA dependent, we determined if micro-
coccal nuclease digestion prevented the interaction in transfected
cells. pp71 co-precipitated with pUL35A and the interaction was not
inhibited by micrococcal nuclease treatment (Fig. 7B). We conclude
that while both pp71 and pUL35A interact with mRNA, the pp71:
pUL35A interaction does not require an RNA intermediate.
Protein synthesis is increased in cells expressing pp71 and pUL35A
Since pp71 and pUL35A both associate with mRNA we investi-
gated the impact of these proteins on the overall rate of protein
synthesis. When expressed alone, pp71 and pUL35A increased total
protein synthesis (Fig. 8A and B) as compared to control cells
expressing GFP. Co-expressing pp71 and pUL35A together increased
protein synthesis to a greater extent than either protein alone.
However, pp71 and pUL35A did not confer stress resistant protein
synthesis as observed during infection (Clippinger et al., 2011;
Lenarcic et al., 2014; Moorman and Shenk, 2010), as inhibiting the
host translation initiation complex eIF4F with an mTOR inhibitor
limited protein synthesis in pp71 and pUL35A expressing cells (data
not shown). While these data do not exclude the possibility that
pp71 and UL35A may globally alter transcription or RNA stability,
the increase in protein synthesis in the presence of pp71 and
pUL35A together with our ﬁnding that pp71 associates with poly-
somes and mRNAs during infection suggest that these proteins act in
concert to increase translation.
Discussion
We have used a rapid, unbiased proteomics method to identify
RNA-associated proteins during viral infection. Our approach
identiﬁed known host RNA-associated proteins and for two such
proteins, DDX3X and DHX9, identiﬁed changes in their abundance
during infection. Importantly, our approach also identiﬁed both
known and previously undescribed HCMV RNA-associated pro-
teins. Using this approach we identiﬁed and conﬁrmed the novel
association of two HCMV proteins, pUS22 and pp71, with mRNA in
infected cells. We also demonstrate for the ﬁrst time that pTRS1, a
known HCMV RNA-binding protein (Hakki and Geballe, 2005),
associates with mRNA during infection. Together these results
demonstrate that this approach captures both nuclear and cyto-
solic HCMV RNA-associated proteins. We also demonstrate a new
activity for the HCMV pp71 protein as an RNA-associated protein
that associates with actively translating host and viral mRNAs
during infection. These results demonstrate that oligo(dT) afﬁnity
chromatography coupled with mass spectrometry is an efﬁcient
means for identifying herpesvirus proteins associated with RNA
during viral infection.
Past studies using oligo(dT) capture coupled with proteomics
have identiﬁed many factors involved in mRNA expression and
metabolism (Baltz et al., 2012; Castello et al., 2012). In this study
we used a similar approach to identify previously undetected
interactions of HCMV proteins with mRNA during lytic infection.
We previously used a similar screen to identify host proteins that
speciﬁcally interact with poliovirus genomic RNA during infection
(Lenarcic et al., 2013). In contrast, HCMV infected cells express
hundreds of viral transcripts as well as thousands of host RNAs.
Thus in this study, oligo(dT) afﬁnity puriﬁcation captures host and
viral proteins associated with either host or HCMV transcripts. The
viral proteins identiﬁed by this approach could therefore be
involved in post-transcriptional regulation of viral transcripts, or
alternatively the expression and metabolism of host mRNAs.
Several aspects of our approach make it easily adaptable for use
in other viral systems. Our approach relies on commercially available
reagents, and comparable mass spectrometers are available in many
academic proteomics core facilities. The relatively small sample size
required suggests this approach could be adapted to identify viral
RNA-binding proteins expressed during lytic or latent infection.
While we could conﬁrm changes in the abundance of host proteins
associated with mRNA, more quantitative mass spectrometry tech-
niques (e.g. SILAC, iTRaQ, reviewed in Munday et al. (2012)) could be
incorporated to precisely measure changes in the abundance of host
or viral RNA-associated proteins throughout a time course of infec-
tion. Applying oligo(dT) coupled proteomics should prove useful in
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Fig. 8. pp71 and UL35A expression increases total protein synthesis. (A) HeLa cells were transfected with plasmids expressing pEGFP, pp71, pUL35A or both pp71 and
pUL35A. Newly synthesized proteins were labeled metabolically and quantiﬁed by liquid scintillation. The results were normalized to the amount of total protein in each
sample and are expressed as percent of counts detected in the GFP control. Error bars indicate the standard error of the mean (n¼6). n¼po0.05, nn¼po0.01, nnn¼po0.001
(B) Radiolabeled proteins from A were separated on SDS-PAGE gels and visualized by autoradiography.
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many viral culture systems for quantitatively identifying proteins,
either host or viral, associated with RNA.
In its current form our approach was sufﬁcient to identify new
activities for pp71 and pUS22 as HCMV RNA-associated proteins.
In addition we could conﬁrm that a known HCMV RNA-binding
protein, HCMV pTRS1, associates with mRNA during HCMV infec-
tion. However, our results also show that our approach is not
comprehensive, as we did not detect the known viral RNA-binding
pUL69 and the pUL35A protein co-puriﬁed with oligo(dT) cellulose
in transfected cells but was not detected in our proteomics screen.
In the case of pUL69 this could reﬂect a relatively low afﬁnity of
pUL69 for RNA, as its RNA-binding ability is not required for its
function as a nuclear export factor for HCMV transcripts (Lischka
et al., 2006). Perhaps the use of more sensitive instrumentation
would provide greater depth. Alternatively, the stringent binding
and wash conditions of our approach were designed to limit false
positives, perhaps giving rise to false negatives. Nonetheless, our
current approach was sufﬁciently sensitive to identify known and
unknown interactions that we could subsequently conﬁrm using
traditional molecular biology techniques.
Our results also identify new RNA-associated roles for previously
characterized HCMV proteins. The HCMV pUS22 protein is an
abundant nuclear protein that is also found in the supernatant of
infected cells (Mocarski et al., 1988). While pUS22 is the namesake
member of a family of related betaherpesvirus proteins (Chee et al.,
1990), no function has been described for HCMV pUS22. Thus our
ﬁnding that pUS22 associates with mRNA is the ﬁrst functional
annotation for pUS22. We hypothesize that pUS22 may play a role in
RNA splicing or export based on its presence at high levels in the
nucleus of infected cells, however additional experiments are
needed to test this hypothesis. Of note is the fact that HCMV pTRS1
is a member of the US22 family of proteins and also associates with
mRNA (Hakki and Geballe, 2005). Perhaps US22 family members
share a common function in the post-transcriptional control of viral
gene expression. This idea is consistent with previous studies
demonstrating a role for pTRS1 and its MCMV homologs as
antagonists of the antiviral kinase PKR (Hakki et al., 2006). It is also
possible that some of the RNA-associated proteins we identiﬁed may
interact with polyadenylated RNAs that are not mRNAs, as some
non-coding RNAs such as lncRNAs can also be polyadenylated
(reviewed in Yoon et al. (2013)).
We also identiﬁed a new function for HCMV pp71 as an mRNA
associated protein. We found that pp71 interacts with mRNA in
infected and transfected cells, associates with polysomes during
infection and stimulates protein synthesis both alone and in con-
junction with its binding partner pUL35A. How the association of
pp71 and pUL35A with mRNA might affect viral gene expression or
replication is currently unclear. pp71 binds to the host BclAF1
protein (Lee et al., 2012), which is a component of an RNP complex
that regulates mRNA processing and transport (Merz et al., 2007).
Perhaps pp71 modulates BclAF1 activity, thereby effecting host or
viral gene expression at the post-transcriptional level. Another
possibility is that pp71 and pUL35A together inhibit cellular stress
responses that would otherwise limit viral protein synthesis.
pUL35A associates with the host G3BP1 protein (Salsman et al.,
2012), which limits translation during viral infections by sequester-
ing mRNAs in cytoplasmic puncta termed stress granules (Tourriere
et al., 2003; Matsuki et al., 2013). Perhaps pUL35A and pp71 limit
stress granule formation or sequestration of viral mRNAs into stress
granules, thereby promoting viral protein synthesis. However it is
also possible that pp71 and UL35A increase protein synthesis
through a global effect on transcription or RNA stability. In any case,
our ﬁnding that pp71 binds to mRNA provides direction for future
studies to deﬁne a role for pp71 in the post-transcriptional control of
gene expression during HCMV infection.
In summary, we show that oligo(dT) afﬁnity capture coupled
with proteomics is a useful approach to identify proteins that
associate with RNA, either host or viral, during infection. Given
recent insights into the surprising complexity of the HCMV
transcriptome, our approach provides a straightforward and prac-
tical means of identifying viral proteins that may manipulate
mRNA processing, export, stability or translation. Our results
identify new activities for viral proteins and also provide new
directions for deﬁning the underlying processes HCMV uses to
regulate viral gene expression.
Materials and methods
Cells and viruses
Human foreskin ﬁbroblasts (HFFs) were maintained in Dulbec-
co's Modiﬁed Eagle Medium (DMEM) with 10% Newborn Calf
Serum (NCS) at 37 1C with 5% CO2 and used between passages
7 and 14. HEK 293T and HeLa cells were maintained in DMEM with
10% Fetal Bovine Serum (FBS). Mutant HCMV AD169 strains
expressing pTRS1 (BADinTRS1GFP) and pUS22 (BADinUS22GFP)
with C-terminal GFP fusion tags under the control of their native
promoters were made by lambda/red-mediated recombineering
(Yu et al., 2003; Sharan et al., 2009) using the BADwt BAC as the
parental strain. HCMV BADinGFP (ADGFP), BADinTRS1GFP and
BADinUS22GFP viruses were grown on HFFs. Unless otherwise
noted, HFFs were infected at an MOI of three for one hour at 37 1C
and 5% CO2 in DMEM plus 10% NCS.
Cloning and transfections
The pp71-HA plasmid was constructed by amplifying the UL82
open reading frame from the BADinGFP BAC using gene speciﬁc
primers that include restriction sites for BamHI and EcoRI as well as
a HA tag sequence for the C terminus of the protein. The amplicon
was ligated into the pcDNA3.1 multi-cloning site in between BamHI
and EcoRI sites. The pUL35A-GFP mammalian expression vector was
produced by amplifying the UL35A open reading frame from the
BADinGFP BAC using gene speciﬁc primers (Forward: GGAG-
ATAGAACCATGATGATCGAGGGCGCCTCTCGGCAGACG, Reverse: CAA-
GAAAGCTGGGTCGAGATGCCGTAGGTTTTCGGCCAGATCG). The ampli-
con was recombined into pDEST47 using Gateway Cloning (Life
Technologies).
Oligo(dT) capture and mass spectrometry
Conﬂuent HFFs were mock infected or infected with ADGFP at
an MOI of three. At 72 hpi the cells were washed with PBS and
harvested by scraping. The cells were pelleted by centrifugation at
2200 rpm for 10 min and resuspended in 1 mL oligo(dT) buffer
(40 mM HEPES pH 7.6, 500 mM NaCl, 1 mM EDTA, 0.3% CHAPS,
Complete EDTA-free protease inhibitor (Roche)) and incubated on
ice for 10 min. Insoluble material was removed by centrifugation
at 4 1C and 15,000 rpm. Where indicated, the supernatant was
treated with micrococcal nuclease for 30 min at room temperature
with rocking. The supernatant was mixed with 10 mg of Oligo(dT)-
Cellulose Type 7 (GE Health Sciences) beads that were rehydrated
in 100 μL oligo(dT) buffer plus 20 mg/mL yeast tRNA prior to
mixing. The slurry was nutated for one hour at 4 1C. The beads
were pelleted and washed thrice with oligo(dT) buffer and twice
with wash buffer (250 mM NaCl, 40 mM HEPES pH 7.6, 1 mM
EDTA, Complete Protease inhibitors, 20 mg/mL yeast tRNA). The
mRNA and bound proteins were eluted in 100 μL elution buffer
(40 mM HEPES pH 7.6, 1 mM EDTA, Complete Protease inhibitors,
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40 mg/mL soluble oligo(dT) with mixing for one hour at 4 1C.
Protein levels were estimated by resolving a 10 μL aliquot of the
eluate on a 10% SDS-PAGE gel and staining with GelCode Blue
(Pierce). The proteins were digested with trypsin in solution and
puriﬁed over C-18 columns. The resulting peptides were identiﬁed
using liquid chromatography coupled tandem mass spectrometry
(LC–MS/MS). MS spectra were searched using the MASCOT algo-
rithm against the current version of the Human IPI database.
Oligo(dT) capture of RNA binding proteins and western blots
Infected HFFs or transfected HEK 293T or HeLa cells were
harvested by scraping and pelleted by centrifugation at 1500 rpm.
Cells were lysed in 1 mL oligo(dT) buffer and incubated on ice for
10 min. Insoluble material was removed by centrifugation at 4 1C
and 15,000 rpm. Where indicated the supernatant was treated with
micrococcal nuclease for 30 min at room temperature with rocking.
The supernatant was then mixed with Oligo (dT)-Cellulose Type 7
(GE Health Sciences) beads and nutated for one hour at 4 1C. The
beads were washed thrice in oligo(dT) buffer and resuspended in
denaturing protein sample buffer (0.1 M Tris–HCl pH 6.8, 6%
Glycerol, 2% SDS, 0.1 M DTT, 0.002% Bromophenol Blue). Proteins
were separated by 10% SDS-PAGE gels and transferred to Protran
nitrocellulose membrane (Whatmann). Blots were probed with
primary antibodies speciﬁc for PABP (1:2000; Cell Signaling), GFP
(1:1000; Roche cat 11814460001) or pp71 (Kalejta et al., 2003)
followed by HRP-conjugated secondary antibodies (KPL) followed by
ECL (Advansta) and visualization on x-ray ﬁlm or using a digital
chemiluminesence detection system (Bio-Rad).
Immunoprecipitations
Transfected HEK 293T or HeLa cells were lysed in 1 mL RIPA
buffer (50 mM Tris–HCl pH 7.4, 1% NP-40, 0.25% sodium deoxycho-
late, 150 mM NaCl, 1 mM EDTA) containing protease inhibitors
(Complete EDTA-free protease inhibitor; Roche) followed by incuba-
tion on ice for 10 min. Insoluble material was removed by centrifu-
gation at 4 1C and 15,000 rpm. The supernatants were then treated
with or without micrococcal nuclease for 30 min at room tempera-
ture with rocking. Supernatants were pre-cleared by nutating with
Protein A/G beads (Santa Cruz Biotechnology) at 4 1C for 30 min. The
pre-clear beads were then pelleted and discarded. The pre-cleared
lysates were then incubated with 2 mg GFP antibody (Roche) at 4 1C
with nutating for one hour. Immune complexes were captured on
Protein A/G sepharose beads by nutating at 4 1C for one hour. The
beads were pelleted and washed thrice in RIPA buffer and resus-
pended in denaturing protein sample buffer. Immune complexes
were resolved on 10% SDS-PAGE gels and analyzed by Western blot.
Identiﬁcation of mRNAs associated with pp71 immune complexes
Infected HFFs were lysed and pre-cleared for immunoprecipita-
tion as above. A portion of the lysate was removed for the isolation
of total RNA. The pre-cleared lysates were then incubated with
100 mL Protein A/G beads that had been pre-conjugated to pp71 or
IE1 antibodies. The immune complexes were formed at 4 1C with
nutating for one hour. The beads were then pelleted and washed
thrice in RIPA buffer before being resuspended in 100 mL RIPA buffer.
10 mL aliquots of resuspended beads were removed, mixed with
protein sample buffer (0.5 M Tris–HCl pH 6.8, 30% Glycerol, 10% SDS,
0.6 M DTT, 0.012% bromophenol blue) and probed by western blot
for pp71 and Tubulin (Sigma). RNA was extracted from the remain-
ing beads with 1 mL Trizol and RNA. cDNA was prepared from the
captured RNAs and total RNA using random hexamer primers and
the High Capacity cDNA Reverse Transcription Kit (Applied Biosys-
tems). Quantitative RT-PCR (qRT-PCR) was performed using a
Lightcycler 480 with SYBR Green Master Mix (Roche) and primers
for
IE1 (Forward: CAAGTGACCGAGGATTGCAA, Reverse: CACCATGTCCA-
CTCGAACCTT), UL44 (Forward: GCGTGCAAGTCTCGACTAAGGAGC,
Reverse: AAGTACTGTGCCTCTTAGTCGGGGG), pp28 (Forward: GTGT-
CCCATTCCCGACTCG, Reverse: TTCACAACGTCCACCCACC) and GAPDH
(Forward: CTGTTGCTGTAGCCAAATTCGT, Reverse: ACCCACTCCTC-
CACCTTTGAC). In order to normalize detected mRNA levels for each
gene, threshold cycles (CT) from immunoprecipitated samples were
normalized back to the CT obtained from total RNA. The normalized
CT for each gene was then compared between the two conditions:
the nonspeciﬁc IE1 control IP and the pp71 IP. The Fold increase for
each gene was calculated from the difference in normalized CT
between these two conditions.
Confocal microscopy
HFFs were plated on glass cover slips and infected at a multi-
plicity of one with the indicated virus strain. At the indicated times
post-infection cells were washed and ﬁxed using 2% paraformalde-
hyde, blocked in 1% BSA for at least one hour at 4 1C and then probed
with pp71 antibodies and ﬂuorescent anti-mouse secondary anti-
bodies. Coverslips were mounted onto slides with Vectashield
mounting solution (Vector Laboratories). Cells were imaged using
a Zeiss CLSM 710 Spectral Confocal Laser Scanning Microscope.
Metabolic labeling of nascent proteins
HeLa cells plated in 6-well dishes were transfected with the
indicated expression plasmids and harvested 24 h after transfec-
tion. Where indicated samples were treated with Torin1 (Thoreen
et al., 2009) (250 nM) or cycloheximide (100 mg/mL) for 16 h prior
to harvest. Forty-ﬁve minutes prior to harvest cell growth media
was replaced with media lacking methionine and cysteine. After
ﬁfteen minutes 125 mCi of 35S-methionine/cysteine was added
(Perkin-Elmer) to the culture media. Cells were labeled for
30 min at 37 1C and then washed twice with ice-cold PBS prior
to harvest by scraping. Cell pellets were lysed in RIPA buffer,
insoluble material was removed by centrifugation at 4 1C and
15,000 rpm, and equal portions of lysate were precipitated in a
solution containing 0.1 mg/mL BSA and 20% TCA. The proteins
were precipitated on ice for thirty minutes and the precipitated
proteins were bound to glass ﬁber ﬁlters (Whatmann) using a
vacuum manifold. The ﬁlters were washed twice with 20% TCA
followed by two washes with 100% ethanol and allowed to air dry
for twenty minutes. Radioactive proteins retained on the ﬁlters
were quantiﬁed in a scintillation counter. Protein concentrations
were determined by Bradford assay. To visualize changes in
nascent protein synthesis, 10 mg of each sample was separated
on 10% SDS-PAGE gels, which were subsequently dried and
visualized by autoradiography.
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